R 61837Alternative Names: R 61387
Latest Information Update: 15 Nov 1994
Price : $50 *
At a glance
- Originator Janssen L.P.
- Class Antivirals
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Common cold
Most Recent Events
- 15 Nov 1994 No-Development-Reported for Common cold in Belgium (Intranasal)
- 15 Nov 1994 No-Development-Reported for Common cold in United Kingdom (Intranasal)